Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection has become one of the most effective medications for sustainable weight loss, with clinical trials showing an average 15% body weight reduction over 68 weeks. Understanding how dosing works—and how your body responds at each adjustment—helps you stay committed to your treatment plan. PlexusDx offers personalized semaglutide therapy from licensed compounding pharmacies, making this powerful tool accessible without insurance or membership requirements.

How Semaglutide Injection Dosing Schedules Work

Semaglutide injection follows a titration protocol, meaning you start at a low dose and gradually increase every week or every few weeks based on your body's tolerance and clinical response. The standard initiation dose is 0.25 mg once weekly, which primes your system to the medication while your body adjusts to appetite suppression and satiety signals. Most patients advance through sequential doses over 16–20 weeks, with each adjustment allowing your GLP-1 receptors to become more responsive while minimizing nausea and gastrointestinal side effects.

The progression typically moves from starter doses through intermediate levels, with many patients reaching their therapeutic target between weeks 12 and 24 of treatment. Your prescribing clinician monitors how you tolerate each dose—tracking hunger reduction, energy levels, and any side effects—before recommending an advance. This individualized approach means some patients find their optimal dose earlier, while others benefit from a slower climb that better suits their metabolism and lifestyle.

Understanding Semaglutide Dose Levels and Weight Loss Outcomes

Lower starter doses (0.25 mg and 0.5 mg weekly) help establish baseline tolerance and typically produce modest appetite reduction and modest weight loss in the first month. As you move into middle-range doses (1.0 mg to 1.7 mg weekly), appetite suppression deepens, food cravings often diminish significantly, and weekly weight loss acceleration typically becomes noticeable on the scale. Higher therapeutic doses (2.0 mg to 2.4 mg weekly) represent the range where most patients experience peak appetite control and the strongest metabolic benefits documented in clinical research.

Individual outcomes vary because genetic factors, baseline metabolic rate, adherence to nutrition changes, and physical activity all influence final results. PlexusDx offers the optional Precision Peptide Genetic Test ($99 add-on after first month), which analyzes your GLP1R, GIPR, FTO, and MC4R variants to help predict how your body's peptide pathways may respond to semaglutide therapy. This genetic insight helps your clinician anticipate whether you'll likely reach your weight loss goals at standard doses or whether a slightly different compound or protocol might serve you better.

Your Price Stays Flat as Your Dose Goes Up

PlexusDx charges a single monthly flat rate for compounded semaglutide injection ($149/mo starting price), regardless of which dose level your clinician prescribes during your treatment journey. This transparent pricing model removes hidden costs and dose-based fee increases, so you pay the same amount in month 3 at 1.0 mg as you paid in month 1 at 0.25 mg. This approach eliminates the financial barrier that sometimes prevents patients from reaching their optimal therapeutic dose—your dose may need to go up, but your price won't.

PlexusDx serves all 50 states with no insurance requirement and accepts HSA and FSA funds, making semaglutide therapy accessible whether you have employer coverage or pay out of pocket. All compounded medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and sterility. Your commitment tier only affects initial enrollment terms, not monthly medication cost, so you maintain predictable budgeting throughout your entire weight loss program.

Managing Side Effects During Dose Advancement

Nausea and appetite loss are expected during the first 7–14 days after starting semaglutide and after each dose increase, but these effects typically peak and then subside within 3–5 days as your body adapts. Staying hydrated, eating smaller meals more frequently, and avoiding greasy or high-fat foods during titration weeks significantly reduces the intensity of GI discomfort. Some patients find ginger tea, smaller protein-focused snacks, or timing meals carefully around their injection day helps them tolerate transitions more comfortably.

Constipation and mild fatigue can also accompany dose increases and usually resolve within a week or two as your system normalizes. If side effects become severe or persistent beyond a week, contact your PlexusDx clinician immediately—they may recommend slowing your titration schedule or adjusting nutritional support. This collaborative monitoring ensures you advance safely while maintaining quality of life, making your weight loss journey sustainable rather than punishing.

Working with PlexusDx Clinicians on Your Dose Schedule

PlexusDx connects you with licensed clinicians who create personalized dosing plans based on your health history, current weight, target weight, and any underlying metabolic conditions. Your clinician reviews your tolerance at each stage, adjusts your titration speed if needed, and helps you integrate dietary and lifestyle changes that amplify semaglutide's weight loss benefits. This personalized oversight—combined with access to genetic testing—ensures your dose schedule aligns with your unique biology rather than a one-size-fits-all protocol.

Throughout your treatment, you'll have regular check-ins to assess progress, troubleshoot side effects, and confirm that your dose adjustment plan remains on track. PlexusDx clinicians also monitor for rare but serious concerns like pancreatitis or thyroid changes, providing medical oversight that standalone compounding services may not offer. This level of personalized clinical support—paired with affordable, transparent pricing and no insurance hassles—makes PlexusDx a complete precision weight loss solution.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How often do I inject semaglutide, and when should I increase my dose?

Semaglutide injection is administered once weekly on the same day each week. Your PlexusDx clinician typically recommends advancing to the next dose every 1–4 weeks based on your tolerance and progress, though some patients benefit from staying at one dose longer before moving up. Your clinician will guide the exact schedule during your regular check-ins.

What does clinical evidence say about semaglutide effectiveness for weight loss?

Major clinical trials (SUSTAIN and STEP programs) show that patients on semaglutide lost 10–15% of body weight on average, with some reaching 18% weight loss at higher doses. These results significantly outperform diet and exercise alone, and benefits extend beyond weight reduction to improved blood sugar, blood pressure, and heart health markers in many patients.

Why does PlexusDx charge a flat monthly rate instead of flat per-compound pricing?

PlexusDx believes treatment should not become more expensive as you progress toward health goals. The flat-rate model ($149/mo for semaglutide injection) removes cost barriers to dose optimization, ensuring financial constraints don't prevent you from reaching your therapeutic target.

Are there safety concerns with dose escalation, and how does PlexusDx monitor for them?

Dose escalation is generally safe when guided by a clinician who monitors your response and adjusts timing if needed. PlexusDx clinicians screen for contraindications, track for rare complications like pancreatitis, and ensure you're not advancing faster than your body can safely tolerate, balancing efficacy with medical safety.

How can the Precision Peptide Genetic Test help me with semaglutide dosing?

The PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to reveal how your body's hunger and metabolism pathways are wired. This insight helps your clinician predict your likely dose response and may suggest whether a dual-compound approach or different medication might work better for your genetic profile.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves